In Vivo PICX CAR-T Therapy for R/R Multiple Myeloma

Clinical trial NCT07715630 · RECRUITING

Trial details

NCT number: NCT07715630
Sponsor: Chongqing Precision Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Multiple Myeloma (RRMM)

Start date: 2026-07-31
Primary completion: 2028-04-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.